Kazushige Wakuda

10PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersBioassaysCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 01, 2026
Efficacy of Docetaxel Plus Ramucirumab for Malignant Pleural Effusion and Cerebral Edema in Patients With Advanced Non-Small Cell Lung Cancer: A Single-Institution Retrospective Study.

|Apr 25, 2026
Efficacy of Osimertinib in Patients With Postoperative Recurrent Non-Small-Cell Lung Cancer Harboring Sensitizing EGFR Mutations.

|Jan 06, 2024
Concordance of ALK fusion gene-rearrangement between immunohistochemistry and next-generation sequencing.

Kazushige Wakuda, Meiko Morita, Motoki Sekikawa

|Jul 18, 2022
Clinical impact of tumour burden on the efficacy of PD-1/PD-L1 inhibitors plus chemotherapy in non-small-cell lung cancer.

Taichi Miyawaki, Hirotsugu Kenmotsu, Kosei Doshita

|Oct 13, 2021
Long-term outcomes in extensive disease small cell lung cancer patients treated without immune checkpoint inhibitors.

Kazushige Wakuda, Michitoshi Yabe, Hiroaki Kodama

|Sep 29, 2021
Impact of angiogenesis inhibitor eligibility on the prognosis of patients with non-small cell lung cancer harboring EGFR mutation.

Hiroaki Kodama, Hirotsugu Kenmotsu, Takanori Kawabata

Pageof 2

Frequent Collaborators

6 joint publications

Haruyasu Murakami

5 joint publications

Tateaki Naito

4 joint publications

Hirotsugu Kenmotsu

3 joint publications

Haruki Kobayashi